Negative impactSector
Yuvraj Singh launches supplement brand Protocol 32, TheLiverDoc calls it ‘in very bad faith’, 'business of bad science'
Mint 1 hr ago·2 Nov 2026, 6:51 am
Former cricketer Yuvraj Singh has launched a new health supplement brand called Protocol 32. The venture has quickly drawn criticism from Dr. Cyriac Abby Philips, a prominent hepatologist known as TheLiverDoc. Dr. Philips has publicly accused the brand of promoting 'bad science' and suggested that the product poses potential health risks to consumers.
This controversy highlights the risks associated with the health and wellness sector, where scientific backing is often questioned. For investors, this situation underscores the importance of due diligence when evaluating companies in this space. A single product controversy can damage the reputation of a brand and negatively impact its stock performance.
Investors should watch for further responses from the company and any regulatory scrutiny regarding the product's claims. The market will likely react to the intensity of the public debate and the company's ability to address the concerns raised by medical professionals.
Excerpt from Mint
Dr. Cyriac Abby Philips, better known as TheLiverDoc on social media, has lashed out at former Indian cricketer Yuvraj Singh after the latter announced his new business venture. On Friday, Singh, in a social media post, introduced Protocol 32, which he claimed contained 32 FSSAI-approved supplements, in the right…Read the original at Mint
Key takeaways
- Category: Sector.
- AI reads the tone as negative (potentially bearish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.
